World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
38776
World Ranking
16388
National Ranking
8246

Overview

Charles L. Daley is affiliated with National Jewish Health in the United States and has made significant contributions to the field of medicine with a focus on infectious diseases, epidemiology, and pulmonary and respiratory medicine. Their research portfolio includes a substantial body of work related to Mycobacterium research and diagnosis as well as tuberculosis research and epidemiology.

The scientist has published extensively, with 195 works classified under the broad field of medicine. Within this, their subfields of study include epidemiology with 76 publications, infectious diseases with 55, pulmonary and respiratory medicine with 39, small animals with 30, and surgery with 9.

Charles L. Daley's research topics center on:

  • Mycobacterium research and diagnosis
  • Tuberculosis Research and Epidemiology
  • Infectious Diseases and Mycology
  • Cystic Fibrosis Research Advances
  • Tracheal and airway disorders
  • Quinazolinone synthesis and applications
  • Pediatric health and respiratory diseases

Frequent coauthors include:

  • Kevin Winthrop
  • David E. Griffith
  • Jerry A. Nick
  • Vinicius Calado Nogueira de Moura
  • Kenneth N. Olivier

Daley has published regularly in high-impact medical journals. The venues with the most publications include:

  • CHEST Journal
  • Journal of Cystic Fibrosis
  • Clinical Infectious Diseases
  • American Journal of Respiratory and Critical Care Medicine
  • European Respiratory Journal

Notable recent papers by Charles L. Daley include:

  • Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline, 2020, European Respiratory Journal
  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline, 2020, Clinical Infectious Diseases
  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline, 2020, Clinical Infectious Diseases

These publications primarily deal with guidelines and treatment approaches for nontuberculous mycobacterial pulmonary disease. Their work often intersects with clinical infectious diseases and respiratory medicine, reflecting a strong clinical and translational research focus.

Best Publications

  • An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

    David E. Griffith;Timothy Aksamit;Barbara A. Brown-Elliott;Antonino Catanzaro

  • American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

    Henry M Blumberg;William J Burman;Richard E Chaisson;Charles L Daley

  • Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

    Charles L. Daley;Jonathan M. Iaccarino;Christoph Lange;Emmanuelle Cambau

  • The Epidemiology of Tuberculosis in San Francisco -- A Population-Based Study Using Conventional and Molecular Methods

    Peter M. Small;Philip C. Hopewell;Samir P. Singh;Antonio Paz

  • Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

    Payam Nahid;Susan E. Dorman;Narges Alipanah;Pennan M. Barry

  • An Outbreak of Tuberculosis With Accelerated Progression Among Persons Infected With the Human Immunodeficiency Virus. An Analysis Using Restriction-Fragment-Length Polymorphisms

    Charles L. Daley;Peter M. Small;Gisela F. Schecter;Gary K. Schoolnik

  • Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli

    MA Behr;SA Warren;H Salamon;PC Hopewell

  • WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

    D. Falzon;E. Jaramillo;H. J. Schünemann;M. Arentz

  • A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

    R L Greenman;R M Schein;M A Martin;R P Wenzel

  • The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

    Wouter Hoefsloot;Jakko Van Ingen;Claire Andrejak;Kristian Ängeby

  • Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

    David M. Lewinsohn;Michael K. Leonard;Philip A. LoBue;David L. Cohn

  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary

    Charles L Daley;Jonathan M Iaccarino;Christoph Lange;Emmanuelle Cambau

  • Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.

    Won Jung Koh;Kyeongman Jeon;Nam Yong Lee;Bum Joon Kim

  • US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

    R. Andres Floto;R. Andres Floto;Kenneth N. Olivier;Lisa Saiman;Charles L. Daley

  • Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing.

    Madhukar Pai;Kaustubh Gokhale;Rajnish Joshi;Sandeep Dogra

  • Epidemiology of human pulmonary infection with nontuberculous mycobacteria

    Theodore K Marras;Charles L Daley

  • Comparison of a Whole-Blood Interferon γ Assay With Tuberculin Skin Testing for Detecting Latent Mycobacterium tuberculosis Infection

    Gerald H. Mazurek;Philip A. LoBue;Philip A. LoBue;Charles L. Daley;John Bernardo

  • Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease

    Julie Jarand;Adrah Levin;Lening Zhang;Gwen Huitt

  • Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives.

    Edward N. Janoff;Robert F. Breiman;Charles L. Daley;Philip C. Hopewell

  • Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.

    Timothy R. Aksamit;Anne E. O’Donnell;Alan Barker;Kenneth N. Olivier

Frequent Co-Authors

Won-Jung Koh
Won-Jung Koh Samsung Medical Center
Kevin L. Winthrop
Kevin L. Winthrop Oregon Health & Science University
Kenneth N. Olivier
Kenneth N. Olivier National Institutes of Health
Philip C. Hopewell
Philip C. Hopewell University of California, San Francisco
Nam Yong Lee
Nam Yong Lee Samsung Medical Center
Jerry A. Nick
Jerry A. Nick National Jewish Health
O Jung Kwon
O Jung Kwon Sungkyunkwan University
Michael R. Knowles
Michael R. Knowles University of North Carolina at Chapel Hill
Peter M. Small
Peter M. Small Bill & Melinda Gates Foundation
Michael J. Strong
Michael J. Strong University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers a wide landscape of related degrees and alternative career pathways, particularly through flexible and accessible online programs. For those interested in fast-tracking their nursing career, direct msn programs online provide an accelerated route for non-nurses to earn a Master’s in Nursing without traditional prerequisites.

Alternatively, online bsn programs for non nurses offer a bachelor’s degree option with less rigorous admission requirements—helpful for career changers or those early in their studies.

Not all healthcare careers require years of medical school. Administrative roles such as medical billing and coding are in high demand. Many reputable medical billing and coding online schools support students with flexible schedules and financial aid options, making this pathway accessible to more learners.

Finally, some nursing schools ease the application process by eliminating standardized entrance tests. nursing schools that don't require teas or hesi exams enable students to focus on other aspects of their application, opening doors for aspiring nurses from varying backgrounds.

Best Scientists Citing Charles L. Daley

Trending Scientists